Photo‐ and Magnetothermally Responsive Nanomaterials for Therapy, Controlled Drug Delivery and Imaging Applications

纳米材料 纳米技术 药物输送 材料科学 表征(材料科学) 光热治疗 涂层 纳米载体 癌症治疗 纳米医学 药品 靶向给药 纳米颗粒
作者
Sohrab Nikazar,Mahmood Barani,Abbas Rahdar,Maryam Zoghi,George Z. Kyzas
出处
期刊:ChemistrySelect [Wiley]
卷期号:5 (40): 12590-12609 被引量:45
标识
DOI:10.1002/slct.202002978
摘要

Abstract Hyperthermia generates heat as a cure for illness and it is not a chemical treatment. Nanomaterials are supposed to provide novel mechanisms to tackle photothermal and magnetothermal problems, with the potential also to deal with specific approaches to care. The present review outlines recent developments in the field of photothermal and magnetothermal responsive nanomaterials and the photothermal approach mechanism over the last years. These photo/magnetothermal nanomaterials are classified into gold nanostructures (various shapes), carbon nanomaterials (CNTs, fullerene, carbon quantum dots, and graphene), inorganic nanomaterials (Fe, Pt, Pd, Bi, MOF, MoSe 2 , inorganic quantum dots, etc.) and organic nanoparticles (PLGA (Poly Lactic‐co‐Glycolic Acid) and other nanopolymers). Different groups may be placed together to improve the potential of the photothermal/magnetothermal effects, treatments, drug delivery, and imaging. The review also describes synthesis strategies for photothermal/magnetothermal nanomaterials, physicochemical characterization, the role of size, size distribution, shape, and surface coating of nanomaterials, challenges, and future scopes of photothermal/magnetothermal responsive nanomaterials for therapy, controlled drug delivery, and imaging applications. The recent development in nanomaterial has shown great potential for tumor diagnostic and therapeutic applications in hyperthermia. Magnetic hyperthermia (also called thermal therapy or thermotherapy) is a type of cancer treatment in which body tissue is exposed to high temperatures (up to 41 °C) in presence of a magnetic field. Research has shown that high temperatures can damage and kill cancer cells, usually with minimal injury to normal tissues. By killing cancer cells and damaging proteins and structures within cells, hyperthermia can necrotize tumor cells. This treatment can be local, regional, or whole‐body hyperthermia, depending on the extent of the area being treated. Hyperthermia can be combined with anticancer drugs or chemotherapy to enhance cancer treatment. In this article, we have discussed recent nanomaterials utilized for this treatment, mechanism, and synthesis methods.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
自由的寄灵完成签到,获得积分10
1秒前
zzzz驳回了田様应助
3秒前
3秒前
冰冰宝完成签到,获得积分10
5秒前
Cheny完成签到 ,获得积分10
5秒前
Owen应助等待的剑身采纳,获得10
8秒前
归鱼发布了新的文献求助10
9秒前
bie123发布了新的文献求助10
9秒前
12秒前
13秒前
小林l完成签到,获得积分20
14秒前
tim完成签到,获得积分10
15秒前
炒栗子发布了新的文献求助10
16秒前
古人发布了新的文献求助10
16秒前
小林l发布了新的文献求助10
18秒前
香蕉觅云应助炒栗子采纳,获得10
24秒前
小学猹完成签到,获得积分10
26秒前
27秒前
汉堡包应助古人采纳,获得10
27秒前
29秒前
CipherSage应助科研通管家采纳,获得10
30秒前
桐桐应助科研通管家采纳,获得10
30秒前
Owen应助科研通管家采纳,获得10
30秒前
无花果应助科研通管家采纳,获得10
30秒前
思源应助科研通管家采纳,获得10
30秒前
orixero应助科研通管家采纳,获得30
30秒前
ding应助科研通管家采纳,获得10
30秒前
NexusExplorer应助科研通管家采纳,获得10
30秒前
bkagyin应助科研通管家采纳,获得10
30秒前
30秒前
烟花应助科研通管家采纳,获得30
30秒前
酷波er应助稳重的小霸王采纳,获得10
30秒前
PJ完成签到,获得积分10
31秒前
周怀宇完成签到,获得积分10
31秒前
Chien完成签到 ,获得积分10
34秒前
古人完成签到,获得积分10
36秒前
liulei_ustb完成签到,获得积分10
37秒前
白菜完成签到 ,获得积分10
38秒前
40秒前
高分求助中
Teaching Social and Emotional Learning in Physical Education 900
Plesiosaur extinction cycles; events that mark the beginning, middle and end of the Cretaceous 800
Recherches Ethnographiques sue les Yao dans la Chine du Sud 500
Two-sample Mendelian randomization analysis reveals causal relationships between blood lipids and venous thromboembolism 500
Chinese-English Translation Lexicon Version 3.0 500
Wisdom, Gods and Literature Studies in Assyriology in Honour of W. G. Lambert 400
薩提亞模式團體方案對青年情侶輔導效果之研究 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2392553
求助须知:如何正确求助?哪些是违规求助? 2097021
关于积分的说明 5283626
捐赠科研通 1824608
什么是DOI,文献DOI怎么找? 909959
版权声明 559943
科研通“疑难数据库(出版商)”最低求助积分说明 486276